Skip to Main content Skip to Navigation

Rôle des cellules dendritiques plasmocytoïdes dans la leucémie myélomonocytaire chronique

Abstract : Bone marrow infiltration with plasmacytoid CD123high cells was identified in a fraction of patients with a chronic myelomonocytic leukemia (CMML), but the mechanisms promoting the generation of these cells and their impact on disease evolution remain poorly known. Using a multiparametric flow cytometry assay, we detect an excess of lineage-negative mononucleated cells expressing CD45, CD123, HLA-DR, BDCA-2, BDCA-4 and CD4 in the bone marrow of 39/161 (24%) CMML patients. Conventional and electron microscopy, flow cytometry and gene expression analyses identify these cells as authentic plasmacytoid dendritic cells (pDCs). These pDCs respond to Toll-like receptor-9 (TLR9) and TLR7 agonists by producing low levels of interferon alpha and high levels of interleukin-8 (IL-8), respectively. Whole exome sequencing of sorted monocytes and pDCs detects one or several mutations that constitutively activate the Ras pathway in every pDC-rich patient, with some subclonal heterogeneity. CD34+ cells from pDC-rich CMML produce high level of pDCs in ex vivo culture, even in the absence of FMS-like tyrosine kinase 3 ligand (FLT-3L). In co-culture experiments, pDCs collected from the bone marrow of pDC-rich CMML decrease the proliferation of CD34+ cells in a dose-dependent manner. pDC increase is associated with an expansion of CD4+ regulatory T cells (Tregs). Retrospective analysis of a cohort of 216 CMML patients detected a mitigated effect of bone marrow infiltration with CD123high, TLC1+ cells on disease outcome, including a trend for a better overall survival of patients with a pDC excess but also an increased risk of leukemic transformation.
Document type :
Complete list of metadatas

Cited literature [412 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Sunday, November 3, 2019 - 1:01:30 AM
Last modification on : Wednesday, October 14, 2020 - 3:41:42 AM
Long-term archiving on: : Tuesday, February 4, 2020 - 7:04:32 PM


Version validated by the jury (STAR)


  • HAL Id : tel-02343621, version 1



Nolwenn Lucas. Rôle des cellules dendritiques plasmocytoïdes dans la leucémie myélomonocytaire chronique. Cancer. Université Paris Saclay (COmUE), 2017. Français. ⟨NNT : 2017SACLS372⟩. ⟨tel-02343621⟩



Record views


Files downloads